Developed & Manufactured by Biomedica
- Products
- By research area
- Bone Metabolism
- Cardiovascular
- Cell proliferation
- immunology
- Infectious disease
- Metabolic Disease
- Nephrology & Transplant
- Neurology
- Oncology
- Oxidative stress
- Toxicity
By product typeDeals of the month
Download biomedica product list
- Services
- ServicesDeals of the month
Our ELISAs:
designed for your clinical
& preclinical application developed & manufactured
byFeatured Products & Promotions
FREE soluble RANKL HS ELISAHigh sensitivity – measurable concentrations in healthy subjectsLearn MoreOsteoprotegerin ELISADay testLearn MoreTotal Soluble Neuropilin-1 ELISAOnly assay that detects free and ligand-bound soluble Neuropilin-1Learn MoreLatest News-
FGF23 (intact) human ELISA as a featured product on Biocompare22 July, 2019The new intact FGF23 ELISA was mentioned in the most recent Biocompare newsletter as a featured product. Check out the drug discovery and development newsletter to learn more. FGF23 (intact) human ELISA Features and Benefits • RELIABLE and FULLY VALIDATED for plasma samples – according to ICH Q2 • SERUM, URINE and CC SUPERNATANT are compatible with [...]
-
FGF23 (intact) human ELISA Launch17 June, 2019BIOMEDICA is happy to announce the launch of its: FGF23 (intact) human ELISA Features and Benefits • RELIABLE and FULLY VALIDATED for plasma samples - according to ICH Q2 • SERUM, URINE and CC SUPERNATANT are compatible with this ELISA • FAST ONE-STEP ELISA - only 3.5 h total incubation time • PLASMA BASED STANDARDS and CONTROLS INCLUDED - for biologically [...]
-
Plasma levels of Semaphorin 4D are decreased by adjuvant tamoxifen but not aromatase inhibitor therapy in breast cancer patients.8 May, 2019Göbel A. et al., J Bone Oncology, 2019; 16: 100237. Full publication. SEMAPHORIN 4D is a soluble and membrane-bound protein that plays important roles in physiologic processes such as vascular growth, tumor progression, and immune cell regulation. Related literature: The Role of Semaphorin 4D in Bone Remodeling and Cancer Metastasis. Lontos K et al., Front [...]
Events-
Biomedica @ ICCBH in Salzburg17 June, 2019Meet Biomedica Immunoassays at poster P95 “Detection of intact FGF23 using a novel well-characterized ELISA” to learn more about new FGF23 (intact) human ELISA and to discuss your research projects! Useful links: Scientific Program FGF23 (intact) human ELISA
-
Biomedica @ ECTS Congress Budapest25 April, 2019May 11 – 14, 2019 Meet Biomedica Immunoassays at the ECTS Congress in Budapest - booth # 12 - to learn more about our soon to be launched new assay and to discuss your research projects!In addition to having a booth, we will present the following posters: Development and characterization of an extraction-free human CGRP [...]
-
Biomedica @ Osteoporoseforum St. Wolfgang23 April, 2019May 9 – 11, 2019 Meet Biomedica Immunoassays at the Osteoporoseforum in St. Wolfgang to learn more about our soon to be launched new assay and to discuss your research projects! intact FGF23 ELISA C-terminal FGF23 ELISA bioactive Slcerostin ELISA Useful links: Scientific Program